ATE278403T1 - Verfahren zur inhibierung von katarakten - Google Patents

Verfahren zur inhibierung von katarakten

Info

Publication number: ATE278403T1
Authority: AT; Austria
Prior art keywords: group; cataracts; inhibiting; inhibiting cataracts; benzoyl
Prior art date: 2000-10-25

Application number

AT01977093T

Other languages

English (en)

Inventor

Pamela Wang Anderson

Andreas Sashegyi

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-25

Filing date

2001-10-12

Publication date

2004-10-15

2001-10-12 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2004-10-15 Application granted granted Critical

2004-10-15 Publication of ATE278403T1 publication Critical patent/ATE278403T1/de

Links

208000002177 Cataract Diseases 0.000 title abstract 2
230000002401 inhibitory effect Effects 0.000 title abstract 2
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
150000001204 N-oxides Chemical class 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01977093T 2000-10-25 2001-10-12 Verfahren zur inhibierung von katarakten ATE278403T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24310100P	2000-10-25	2000-10-25
US25380000P	2000-11-29	2000-11-29
PCT/US2001/027766 WO2002034266A1 (en)	2000-10-25	2001-10-12	Method for inhibiting cataracts

Publications (1)

Publication Number	Publication Date
ATE278403T1 true ATE278403T1 (de)	2004-10-15

Family

ID=26935594

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01977093T ATE278403T1 (de)	2000-10-25	2001-10-12	Verfahren zur inhibierung von katarakten

Country Status (7)

Country	Link
US (1)	US20040087572A1 (de)
EP (1)	EP1335727B1 (de)
AT (1)	ATE278403T1 (de)
AU (1)	AU2001296240A1 (de)
DE (1)	DE60106293T2 (de)
ES (1)	ES2228958T3 (de)
WO (1)	WO2002034266A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100112881A1 (en) *	2008-11-03	2010-05-06	Pradip Bahukudumbi	Composite material and method for manufacturing composite material
WO2015122954A2 (en) *	2013-11-27	2015-08-20	Humanetics Corporation	Protecting tissue and mitigating injury from chemical exposure
AU2017312499B2 (en)	2016-08-19	2023-02-02	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5451589A (en) *	1993-12-21	1995-09-19	Eli Lilly And Company	Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
US5478847A (en) *	1994-03-02	1995-12-26	Eli Lilly And Company	Methods of use for inhibiting bone loss and lowering serum cholesterol

2001
- 2001-10-12 EP EP01977093A patent/EP1335727B1/de not_active Expired - Lifetime
- 2001-10-12 US US10/380,450 patent/US20040087572A1/en not_active Abandoned
- 2001-10-12 WO PCT/US2001/027766 patent/WO2002034266A1/en not_active Ceased
- 2001-10-12 ES ES01977093T patent/ES2228958T3/es not_active Expired - Lifetime
- 2001-10-12 AT AT01977093T patent/ATE278403T1/de not_active IP Right Cessation
- 2001-10-12 DE DE60106293T patent/DE60106293T2/de not_active Expired - Fee Related
- 2001-10-12 AU AU2001296240A patent/AU2001296240A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1335727A1 (de)	2003-08-20
US20040087572A1 (en)	2004-05-06
DE60106293D1 (de)	2004-11-11
DE60106293T2 (de)	2005-11-17
WO2002034266A8 (en)	2003-11-06
EP1335727B1 (de)	2004-10-06
AU2001296240A1 (en)	2002-05-06
WO2002034266A9 (en)	2002-08-15
ES2228958T3 (es)	2005-04-16
WO2002034266A1 (en)	2002-05-02

Similar Documents

Publication	Publication Date	Title
AP1541A (en)	2006-01-11	New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors.
BR0111596A (pt)	2004-03-02	Composto e seu uso, processo para sua produção, composição farmacêutica e processo e método para prevenir ou tratar doenças
IL165262A (en)	2011-10-31	Kinase inhibitors and pharmaceutical compositions containing them
ATE211147T1 (de)	2002-01-15	Tripeptidisches antithrombotisches mittel
TR200302242T2 (tr)	2004-12-21	Protein kinaz önleyicileri olarak pirolopirimidinler
DK0738262T3 (da)	2000-09-04	Hidtil ukendte heterocykliske forbindelser
NO944927L (no)	1995-06-22	Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom
RU2011105813A (ru)	2012-08-27	Азотсодержащие гетероциклические соединения
ATE468109T1 (de)	2010-06-15	Liposomale abgabe von verbindungen auf vitamin-e- basis
MX9707531A (es)	1997-11-29	Nuevos compuestos heterociclicos.
DE602004011255D1 (de)	2008-02-21	Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
ATE274608T1 (de)	2004-09-15	Säureätzlösung und verfahren zur behandlung von kupfer
DE602004020730D1 (de)	2009-06-04	Pharmazeutisches verfahren und damit hergestellte verbindungen
EA200100090A2 (ru)	2001-08-27	Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
ATE476431T1 (de)	2010-08-15	Piperidin- und azetidinderivate als glyt1- inhibitoren
EA200101230A1 (ru)	2002-06-27	Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
ATE278403T1 (de)	2004-10-15	Verfahren zur inhibierung von katarakten
HUP0204501A2 (hu)	2003-04-28	Gyűrűs vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására és alkalmazásuk
HUP0303020A2 (hu)	2003-12-29	Androgén 7-szubsztituált 11-halogénezett szteroidok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE60110233D1 (de)	2005-05-25	Neue n-(2-phenyl-3-aminopropyl)naphtamide
ATE308513T1 (de)	2005-11-15	Naphthamid-neurokinin antagonisten zur verwendung als medikamente
ATE365162T1 (de)	2007-07-15	Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
KR960014107A (ko)	1996-05-22	피리미디닐 아크릴산 유도체
DE60117783D1 (de)	2006-05-04	Naphthamidin-urokinasinhibitoren
HUP0102506A2 (hu)	2002-01-28	Benzotiofénszármazékok alkalmazása az acetil-kolin szint növelésére

Legal Events

Date	Code	Title	Description
2005-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties